The Signal Directory
Founders, investors, health system and payer leaders, policy people and analysts. Filter by the part of the industry they work in and where they post.
Looking for practising clinicians instead? Open the clinician directory.
Co-Founder and CEO, Anthropic
Leads Anthropic as it expands Claude from general-purpose AI into healthcare, scientific research and life sciences workflows.
Frontier AI / Scientific AI / AI Safety
Best for: AI researchers and life sciences executives
Founder and CEO, insitro
Explores how advanced machine learning can transform drug discovery and clinical development, sharing key updates on predictive biology and therapeutic design.
Machine Learning / Drug Discovery / Computational Biology
Best for: AI researchers and computer-aided drug discovery specialists
Chair and CEO, Eli Lilly and Company
Leads Lilly through one of the strongest periods in modern pharma, from incretins to targeted oncology.
Oncology / Drug development / Biopharma strategy
Best for: Readers tracking big pharma strategy and pipeline decisions.
Partner, Atlas Venture
Offers detailed, data-driven analysis of biotech venture capital trends, early-stage drug development, and the financial ecosystem supporting new therapeutics.
Biotech Investing / Drug Discovery / Venture Capital
Best for: Biotech founders, venture capitalists, and life sciences executives
Chairman and Chief Executive Officer, Pfizer
Follow him for corporate updates, thoughts on scientific breakthroughs, global health initiatives, and executive leadership insights directly from the helm of one of the world's largest pharmaceutical companies.
vaccine development / pharmaceutical innovation / global health equity
Best for: Pharma executives and healthcare industry watchers
Professor of Chemistry and Nobel Laureate, Stanford University
Offers an engaging window into high level chemistry research, drug development startups, diversity in science, and celebration of academic breakthroughs.
bioorthogonal chemistry / therapeutic discovery / academic biotech
Best for: Life science researchers and chemistry students
Professor and Nobel Laureate, University of Szeged
She posts inspiring reflections on her career long research into mRNA technology, developments in molecular biology, and international collaboration in sciences.
mRNA research / biotechnology history / scientific perseverance
Best for: Research scientists and biotechnology students
Chief Executive Officer, Moderna
Offers updates on the progress of mRNA pipelines, biotechnology scaling challenges, and his vision for the future of personalized medicine and vaccine development.
mRNA technology / biotech scaleup / preventative medicine
Best for: Biotech founders, investors, and mRNA enthusiasts
Chief Scientific Officer, Eli Lilly and Company
The scientist behind Lilly's pipeline, including the EMBER-3 programme behind the Inluriyo approval.
Drug discovery / Oncology / Clinical development
Best for: Readers who follow how big pharma R&D portfolios are built.
Chief Executive Officer, Novartis
He shares highly engaging behind the scenes video updates, insights on drug manufacturing, leadership lessons, and perspectives on how digital transformation is changing medicine.
drug development / healthcare leadership / gene therapy
Best for: Life sciences leaders and aspiring healthcare executives
Senior Writer, Medicine, STAT
Widely regarded as one of the premier journalists in medicine and biotech, providing sharp, objective analysis of clinical trial results and pharmaceutical policy decisions.
biotech journalism / clinical trial data / FDA approvals
Best for: Anyone wanting unbiased analysis of biotech developments
Founder and Co-CEO, Insilico Medicine
Provides regular updates on the application of generative AI to chemistry and biology, clinical trial milestones, and longevity research.
Generative AI / Longevity Research / Drug Discovery
Best for: AI engineers, medicinal chemists, and biotech entrepreneurs
Director of Chemical Biology and Author, Novartis
He writes the highly respected blog In the Pipeline, offering deep technical analyses of organic chemistry, drug candidate failures, and the realities of modern drug discovery.
medicinal chemistry / drug discovery / clinical trials
Best for: Medicinal chemists and drug discovery researchers
Founder and Principal, JMaraganore Consulting
Shares valuable executive-level mentorship, insights on biotech corporate governance, and expert perspectives on the next generation of genomic and molecular therapies.
RNA Interference / Biotech Leadership / Drug Development
Best for: Biotech executives, drug developers, and researchers
Founder, President and CEO, Ultragenyx Pharmaceutical
Leads Ultragenyx’s development of therapies for rare and ultrarare diseases, including the approved MPS IIIA gene therapy Fayuvi.
Rare Disease / Gene Therapy / Drug Development
Best for: Rare-disease founders and drug developers
CEO, Loncar Investments
Offers real-time commentary on biotechnology stock markets, clinical trial readouts, and global pharmaceutical industry trends, including a strong focus on Chinese biotech.
Biotech Investing / Cancer Immunotherapy / Global Pharma
Best for: Public market biotech investors and industry analysts
Life Sciences Research Lead, Anthropic
Former Coefficient Bio co-founder leading drug discovery and development research within Anthropic’s expanding life sciences group.
Drug Discovery / Generative Biology / Foundation Models
Best for: Computational biology and drug discovery teams
Managing Partner, RA Capital Management
Writes extensively on drug pricing policy, patent ecosystems, biotech capital markets, and the societal value of pharmaceutical innovation.
Biotech Policy / Drug Pricing / Venture Capital
Best for: Healthcare policy analysts, biotech executives, and investors
Founder and Advisor, Clinical Innovation Partners
Delivers deep insights into the modernization of clinical trials, decentralization strategies, digital health tools, and patient advocacy integration in drug development.
Clinical Trials / Decentralized Trials / Patient Centricity
Best for: Clinical trial operations managers and digital health innovators
Founder and CEO, Exscientia
Offers visionary leadership perspectives on automated drug design, automated chemistry, and using patient-tissue-led platforms for oncology clinical trials.
AI Drug Design / Precision Oncology / Automated Chemistry
Best for: Computational chemists and precision medicine advocates
Head of Biology and Life Sciences, Anthropic
Leads Anthropic’s biology and life sciences work, connecting frontier models with practical scientific research and development workflows.
Life Sciences AI / Biology / Scientific Computing
Best for: Life sciences AI builders and researchers
Co-Founder and CEO, Owkin
Discusses how federated learning and artificial intelligence can optimize clinical trials, discover new biomarkers, and advance precision oncology.
AI in Oncology / Precision Medicine / Federated Learning
Best for: Oncologists, data scientists, and pharmaceutical researchers
Executive Chairman and Co-founder, IntraBio
Co-founded the company that won FDA approval for the first ataxia treatment in ataxia telangiectasia.
Rare disease / Orphan drugs / Neurology
Best for: Readers following rare disease drug development.
Executive Chairperson and Interim CEO, Lantheus
Follow for leadership perspective on radiopharmaceutical diagnostics and therapeutics, including Lantheus product and regulatory milestones.
Radiopharmaceuticals / Life sciences leadership / Oncology
Best for: Life sciences operators and investors
Member of Technical Staff, Anthropic
Former Coefficient Bio co-founder developing AI agents and experimental-design systems for scientific discovery at Anthropic.
Scientific AI / Experimental Design / Drug Discovery
Best for: Scientific AI researchers and biotech builders
Co-Founder and CEO, ImpriMed
Builds precision-oncology systems combining live patient-derived cancer-cell assays with multimodal data and AI-supported treatment insights.
Precision Oncology / Functional Testing / Multimodal AI
Best for: Precision medicine and oncology builders
Chief Executive Officer, Mirum Pharmaceuticals
Follow the Mirum chief executive for rare-disease drug development and commercial strategy, including the zilurgisertib program for fibrodysplasia ossificans progressiva.
Rare disease / Drug development / Biopharma
Best for: Rare-disease biopharma operators
Senior Vice President, INES Development, AbbVie
Follow AbbVie clinical development leadership working across immunology, neuroscience, eye care and specialty medicines, including the Parkinson disease tavapadon program.
Drug development / Neuroscience / Immunology
Best for: Pharma development leaders and neuroscience teams
Chief Executive Officer, RegCell
Leading epigenetic Treg reprogramming, co-founded with Nobel laureate Shimon Sakaguchi, backed by a $44M Series A.
Cell therapy / Autoimmune disease / Transplant tolerance
Best for: Researchers and investors following regulatory T-cell and autoimmune platforms
Co-Founder & CEO, HexemBio
Rejuvenating aged blood stem cells with a synthetic yolk sac platform, backed by Draper Associates and Boost VC.
Synthetic biology / Stem cells / Longevity
Best for: Builders and investors watching stem cell rejuvenation and transplant science
Showing 30 of 190 people. Listings are editorial, not paid, and nobody pays to appear here.
